Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × Lipoma × Clear all

Phase

Phase 1 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

INDIV 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 571 Breast Neoplasms 482 Neoplasms 388 Colorectal Neoplasms 248 Prostatic Neoplasms 227 Neoplasm Metastasis 220 Melanoma 204 Recurrence 182 Ovarian Neoplasms 181 Multiple Myeloma 162 Lung Neoplasms 161 Pancreatic Neoplasms 132 Lymphoma, Non-Hodgkin 130 Leukemia, Myeloid, Acute 125 Carcinoma, Hepatocellular 121 Stomach Neoplasms 115 Lymphoma 108 Carcinoma, Renal Cell 104 Glioblastoma 101 Head and Neck Neoplasms 94 Squamous Cell Carcinoma of Head and Neck 93 Lymphoma, Large B-Cell, Diffuse 87 Lymphoma, Follicular 85 Leukemia, Lymphocytic, Chronic, B-Cell 85 Leukemia 84 Small Cell Lung Carcinoma 79 Brain Neoplasms 79 Carcinoma 67 Uterine Cervical Neoplasms 64 Sarcoma 60

Interventions

Deoxycholic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00608842 2016-01-14

Phase 2 Study for the Treatment of Superficial Lipomas

Kythera Biopharmaceuticals

Phase 2 Completed

62 enrolled 12 charts

Lipoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡